You don’t need to be an expert in economics to recognize that when kids get cancer and need either expensive or unprofitable treatments, capitalism clashes with medical ethics and basic human decency. In childhood cancer, unprofitability can actually be the bigger threat than high cost.

Many forms of childhood cancer are curable with cheap, tried-and-true generic drugs — meaning that industry isn’t eager to make these prescriptions, so they aren’t always available when a child needs them.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.